HLA-DRB1 Alleles Are Associated with Different Magnitudes of Dengue Virus-Specific CD4+ T-Cell Responses

Journal of Infectious Diseases

Volumn 214, Issue 7, 2016, Pages 1117-1124

  Weiskopf, Daniela ^a   Angelo, Michael A ^a   Grifoni, Alba ^a   O'Rourke, Patrick H ^a   Sidney, John ^a   Paul, Sinu ^a   De Silva, Aruna D ^a,c   Phillips, Elizabeth ^b,g   Mallal, Simon ^b,g   Premawansa, Sunil ^d   Premawansa, Gayani ^e   Wijewickrama, Ananda ^f   Peters, Bjoern ^a   Sette, Alessandro ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c Genetech Research Institute   (United States)

^d University of Colombo   (United States)

^e Department of Anaesthesiology College of Anaesthesiologists and Intensivists of Sri Lanka   (Sri Lanka)

^f National Institute of Infectious Diseases   (Sri Lanka)

^g MURDOCH UNIVERSITY   (Australia)

Author keywords

CD4+ T cells; Dengue virus; disease association; HLA

Indexed keywords

CAPSID PROTEIN; EPITOPE; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 3; NONSTRUCTURAL PROTEIN 5; PROTEIN C; UNCLASSIFIED DRUG; VIRAL PROTEIN; HLA DRB1 ANTIGEN;

ALLELE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONFERENCE PAPER; CONTROLLED STUDY; DENGUE VIRUS; DISEASE SEVERITY; GENE; HLA DRB1 GENE; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; SRI LANKAN; VALIDATION STUDY; ADULT; DENGUE; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ADULT; CD4-POSITIVE T-LYMPHOCYTES; DENGUE; DENGUE VIRUS; EPITOPES, T-LYMPHOCYTE; HLA-DRB1 CHAINS; HUMANS;

EID: 84994162821     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiw309     Document Type: Conference Paper

References (28)

1. McKinstry KK, Strutt TM, Swain SL. The potential of CD4 T-cell memory. Immunology 2010; 130:1-9.
2. Goncalves AJ, Oliveira ER, Costa SM, et al. Cooperation between CD4+ T Cells and Humoral Immunity Is Critical for Protection against Dengue Using a DNA Vaccine Based on the NS1 Antigen. PLoS Negl Trop Dis 2015; 9:e0004277.
3. Kurane I, Matsutani T, Suzuki R, et al. T-cell responses to dengue virus in humans. Trop Med Health 2011; 39:45-51.
4. Yauch LE, Prestwood TR, May MM, et al. CD4+ T cells are not required for the induction of dengue virus-specific CD8+ T cell or antibody responses but contribute to protection after vaccination. J Immunol 2010; 185:5405-16.
5. Halstead SB. Neutralization and antibody-dependent enhancement of dengue viruses. Adv Virus Res 2003; 60:421-67.
6. Zellweger T, Chi K, Miyake H, et al. Enhanced radiation sensitivity in prostate cancer by inhibition of the cell survival protein clusterin. Clin Cancer Res 2002; 8:3276-84.
7. Weiskopf D, Bangs DJ, Sidney J, et al. Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity. Proc Natl Acad Sci USA 2015; 112:E4256-63.
8. Weiskopf D, Angelo MA, de Azeredo EL, et al. Comprehensive analysis of dengue virus-specific responses supports an HLA-linked protective role for CD8+ T cells. Proc Natl Acad Sci USA 2013; 110:E2046-53.
9. Weiskopf D, Cerpas C, Angelo MA, et al. Human CD8+ T-Cell Responses Against the 4 Dengue Virus Serotypes Are Associated With Distinct Patterns of Protein Targets. J Infect Dis 2015; 212:1743-51.
10. Malavige GN, Rostron T, Rohanachandra LT, et al. HLA class I and class II associations in dengue viral infections in a Sri Lankan population. PLoS One 2011; 6: e20581.
11. Nguyen TP, Kikuchi M, Vu TQ, et al. Protective and enhancing HLA alleles, HLADRB1 0901 and HLA-A24, for severe forms of dengue virus infection, dengue hemorrhagic fever and dengue shock syndrome. PLoS Negl Trop Dis 2008; 2:e304.
12. Carrasco Pro S, Sidney J, Paul S, et al. Automatic Generation of Validated Specific Epitope Sets. J Immunol Res 2015; 2015:763461.
13. Pham J, Oseroff C, Hinz D, et al. Sequence conservation predicts T cell reactivity against ragweed allergens. Clin Exp Allergy 2016; doi:10.1111/cea.12772.
14. Kanakaratne N, Wahala WM, Messer WB, et al. Severe dengue epidemics in Sri Lanka, 2003-2006. Emerg Infect Dis 2009; 15:192-9.
15. Kraus AA, MesserW, Haymore LB, de Silva AM. Comparison of plaque-and flow cytometry-based methods for measuring dengue virus neutralization. J Clin Microbiol 2007; 45:3777-80.
16. Wang P, Sidney J, Dow C, Mothe B, Sette A, Peters B. A systematic assessment of MHC class II peptide binding predictions and evaluation of a consensus approach. PLoS Comput Biol 2008; 4:e1000048.
17. Wang P, Sidney J, Kim Y, et al. Peptide binding predictions for HLA DR, DP and DQ molecules. BMC Bioinformatics 2010; 11:568.
18. Assarsson E, Sidney J, Oseroff C, et al. A quantitative analysis of the variables affecting the repertoire of T cell specificities recognized after vaccinia virus infection. J Immunol 2007; 178:7890-01.
19. Kotturi MF, Scott I, Wolfe T, et al. Naive precursor frequencies and MHC binding rather than the degree of epitope diversity shape CD8+ T cell immunodominance. J Immunol 2008; 181:2124-33.
20. Yewdell JW, Bennink JR. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu Rev Immunol 1999; 17:51-88.
21. Kotturi MF, Peters B, Buendia-Laysa F Jr, et al. The CD8+ T-cell response to lymphocytic choriomeningitis virus involves the L antigen: uncovering new tricks for an old virus. J Virol 2007; 81:4928-40.
22. Oseroff C, Sidney J, Vita R, et al. T cell responses to known allergen proteins are differently polarized and account for a variable fraction of total response to allergen extracts. J Immunol 2012; 189:1800-11.
23. Paul S, Lindestam Arlehamn CS, Scriba TJ, et al. Development and validation of a broad scheme for prediction of HLA class II restricted T cell epitopes. J Immunol Methods 2015; 422:28-34.
24. Vita R, Overton JA, Greenbaum JA, et al. The immune epitope database (IEDB) 3.0. Nucleic Acids Res 2015; 43:D405-12.
25. Rivino L, Kumaran EA, Jovanovic V, et al. Differential targeting of viral components by CD4+ versus CD8+ T lymphocytes in dengue virus infection. J Virol 2013; 87:2693-706.
26. Gil L, Izquierdo A, Lazo L, et al. Capsid protein: evidences about the partial protective role of neutralizing antibody-independent immunity against dengue in monkeys. Virology 2014; 456-457:70-6.
27. Guy B, Briand O, Lang J, Saville M, Jackson N. Development of the Sanofi Pasteur tetravalent dengue vaccine: One more step forward. Vaccine 2015; 33:7100-11.
28. de Alwis R, Bangs DJ, Angelo MA, et al. Immunodominant dengue virus specific CD8+ T cells responses are associated with a memory PD-1+ phenotype. J Virol 2016; 90:4771-9.